Soda Nikka Co. Ltd. logo

Soda Nikka Co. Ltd. (8158)

Market Closed
13 Aug, 06:00
JPX JPX
¥
1,309. 00
-11
-0.8333%
¥
- Market Cap
- P/E Ratio
0.04% Div Yield
69,200 Volume
- Eps
¥ 1,320
Previous Close
Add Transaction
Day Range
1,298 1,327
Year Range
975 1,388
Want to track 8158 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8158 closed yesterday lower at ¥1,309, a decrease of -0.8333% from Wednesday's close, completing a monthly increase of 16.3556% or ¥184. Over the past 12 months, 8158 stock gained 19.8718%.
8158 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥22.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Soda Nikka Co. Ltd. has completed 4 stock splits, with the recent split occurring on Aug 23, 2023.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

8158 Chart

Soda Nikka Co. Ltd. (8158) FAQ

What is the stock price today?

The current price is ¥1,309.00.

On which exchange is it traded?

Soda Nikka Co. Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 8158.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.04%.

What is its market cap?

As of today, no market cap data is available.

Has Soda Nikka Co. Ltd. ever had a stock split?

Soda Nikka Co. Ltd. had 4 splits and the recent split was on Aug 23, 2023.

Soda Nikka Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Chuang Wang CEO
JPX Exchange
JP3431400005 ISIN
Hong Kong Country
39 Employees
- Last Dividend
23 Aug 2023 Last Split
- IPO Date

Overview

China Regenerative Medicine International Limited operates as an investment holding company primarily in Hong Kong and the People's Republic of China. It specializes in the production and sale of healthcare products and services, focusing on the development of treatments and solutions that encourage the body's natural regenerative processes. The enterprise has undergone significant transformations since its establishment in 1995, including a name change from China Bio-Med Regeneration Technology Limited to its current designation in March 2015. With its headquarters situated in Tsim Sha Tsui, Hong Kong, the company continues to pioneer in the field of regenerative medicine, promoting health and wellness across varied demographics.

Products and Services

China Regenerative Medicine International Limited offers a comprehensive suite of healthcare products and services tailored to enhance overall well-being and address specific health issues. Their offerings include:

  • Health Management Services: Catering to individual health needs, these services offer a thorough assessment of the patient's health situation, followed by treatments focused on detoxification, balancing the inner body, nourishment of organs, and boosting the immune system. The goal is to holistically improve health and prevent disease.
  • Beauty Services: Aiming at both aesthetic enhancement and skin health, their beauty services span from non-surgical medical aesthetic treatments to basic skincare. Offerings also extend to solutions for maintaining youthful skin, hair revitalization, lines firming, and partial remodeling. Furthermore, intimate rejuvenation treatment services are available, which showcase the company’s commitment to comprehensive wellness and beauty care.

Contact Information

Address: Miramar Tower
Phone: 852 3918 9000